Otsuka (OTCMKTS:OTSKY – Get Free Report) is one of 907 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its rivals? We will compare Otsuka to similar companies based on the strength of its dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership.
Insider and Institutional Ownership
32.8% of shares of all “Pharmaceuticals” companies are owned by institutional investors. 14.0% of shares of all “Pharmaceuticals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Otsuka and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Otsuka | 15.50% | 12.93% | 9.55% |
| Otsuka Competitors | -2,324.62% | -215.62% | -16.81% |
Valuation & Earnings
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Otsuka | $16.51 billion | $2.43 billion | 15.52 |
| Otsuka Competitors | $3.53 billion | $3.12 billion | 536.88 |
Otsuka has higher revenue, but lower earnings than its rivals. Otsuka is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Dividends
Otsuka pays an annual dividend of $0.26 per share and has a dividend yield of 0.7%. Otsuka pays out 10.4% of its earnings in the form of a dividend. As a group, “Pharmaceuticals” companies pay a dividend yield of 3.7% and pay out 48.3% of their earnings in the form of a dividend.
Volatility and Risk
Otsuka has a beta of -0.04, suggesting that its share price is 104% less volatile than the S&P 500. Comparatively, Otsuka’s rivals have a beta of -3.23, suggesting that their average share price is 423% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of current ratings and price targets for Otsuka and its rivals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Otsuka | 1 | 2 | 1 | 0 | 2.00 |
| Otsuka Competitors | 7633 | 13734 | 25638 | 1001 | 2.42 |
As a group, “Pharmaceuticals” companies have a potential upside of 31.46%. Given Otsuka’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Otsuka has less favorable growth aspects than its rivals.
Summary
Otsuka rivals beat Otsuka on 9 of the 15 factors compared.
Otsuka Company Profile
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
